HealthWell: AutoImmune - Medicare Access

Not Funded
About
The HealthWell: AutoImmune - Medicare Access program offers essential support for patients on Medicare who are being treated for conditions like Ankylosing Spondylitis, Psoriasis, Psoriatic Arthritis, or Rheumatoid Arthritis. With coverage for a wide range of medications such as Actemra and Humira, the program provides financial assistance for copays and premiums, allowing patients to receive necessary treatments without financial burden. Eligible patients have the convenience of applying online or by phone, maximizing accessibility to the assistance provided by HealthWell: AutoImmune - Medicare Access.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
HealthWell: AutoImmune - Medicare Access
Benefits
$2800 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
This fund covers the following Therapy Areas: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Psoriasis (PsO), and Ankylosing Spondylitis (AS)
Please note that this copay/premium fund may cover offlabel drugs
No Minimum copay reimbursement amount and No Minimum premium reimbursement amount
Eligible patients can complete the application process online or by phone
Patients must submit the Diagnosis Verification form (completed & signed by provider), copy of insurance cards, and prescription cards through the portal or by fax (18002827692) within 30 days of application
Approved patients will receive a letter detailing assistance. They can access their grant by using their ‘HealthWell Foundation Copayment Assistance Card’, by asking their provider’s office or pharmacy to direct bill with HealthWell, or by paying up front and submitting claim to HealthWell for direct reimbursement
Patients will have one full year to use the grant before needing to reenroll (Grants are given on a firstcome, firstserved basis)
For grants to remain active, the first complete reimbursement request must be received within 90 days of approval date, and continue at least every 90 days
Grants with no activity for over 90 days will be considered inactive and closed
Patients who are approved for a grant but do not use a portion of their grant money may not be able to reenroll
Other Tools for
Check Drug Interactions